Report Detail
Global Human Milk Oligosaccharides (HMO) Market Insights, Forecast to 2025
- RnM2888435 |
- 14 February, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Food & Beverages
Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces.
The global Human Milk Oligosaccharides (HMO) market is valued at 110 million US$ in 2018 and will reach 720 million US$ by the end of 2025, growing at a CAGR of 27.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Human Milk Oligosaccharides (HMO) market based on company, product type, end user and key regions.
This report studies the global market size of Human Milk Oligosaccharides (HMO) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Human Milk Oligosaccharides (HMO) in these regions.
This research report categorizes the global Human Milk Oligosaccharides (HMO) market by top players/brands, region, type and end user. This report also studies the global Human Milk Oligosaccharides (HMO) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Abbott
Inbiose
Company two
Jennewein Biotechnologie
Glycom
ZuChem
Dextra Laboratories
Market size by Product
Neutral
Acidic
Market size by End User
Food Industry
Laboratory Research
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Human Milk Oligosaccharides (HMO) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Human Milk Oligosaccharides (HMO) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Human Milk Oligosaccharides (HMO) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Human Milk Oligosaccharides (HMO) submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Human Milk Oligosaccharides (HMO) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Human Milk Oligosaccharides (HMO) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Human Milk Oligosaccharides (HMO) Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Product
- 1.4.2 Neutral
- 1.4.3 Acidic
- 1.5 Market by End User
- 1.5.1 Global Human Milk Oligosaccharides (HMO) Market Size Growth Rate by End User
- 1.5.2 Food Industry
- 1.5.3 Laboratory Research
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Human Milk Oligosaccharides (HMO) Market Size
- 2.1.1 Global Human Milk Oligosaccharides (HMO) Revenue 2014-2025
- 2.1.2 Global Human Milk Oligosaccharides (HMO) Sales 2014-2025
- 2.2 Human Milk Oligosaccharides (HMO) Growth Rate by Regions
- 2.2.1 Global Human Milk Oligosaccharides (HMO) Sales by Regions
- 2.2.2 Global Human Milk Oligosaccharides (HMO) Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Human Milk Oligosaccharides (HMO) Sales by Manufacturers
- 3.1.1 Human Milk Oligosaccharides (HMO) Sales by Manufacturers
- 3.1.2 Human Milk Oligosaccharides (HMO) Sales Market Share by Manufacturers
- 3.1.3 Global Human Milk Oligosaccharides (HMO) Market Concentration Ratio (CR5 and HHI)
- 3.2 Human Milk Oligosaccharides (HMO) Revenue by Manufacturers
- 3.2.1 Human Milk Oligosaccharides (HMO) Revenue by Manufacturers (2014-2019)
- 3.2.2 Human Milk Oligosaccharides (HMO) Revenue Share by Manufacturers (2014-2019)
- 3.3 Human Milk Oligosaccharides (HMO) Price by Manufacturers
- 3.4 Human Milk Oligosaccharides (HMO) Manufacturing Base Distribution, Product Types
- 3.4.1 Human Milk Oligosaccharides (HMO) Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Human Milk Oligosaccharides (HMO) Product Type
- 3.4.3 Date of International Manufacturers Enter into Human Milk Oligosaccharides (HMO) Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Human Milk Oligosaccharides (HMO) Sales by Product
- 4.2 Global Human Milk Oligosaccharides (HMO) Revenue by Product
- 4.3 Human Milk Oligosaccharides (HMO) Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Human Milk Oligosaccharides (HMO) Breakdown Data by End User
6 North America
- 6.1 North America Human Milk Oligosaccharides (HMO) by Countries
- 6.1.1 North America Human Milk Oligosaccharides (HMO) Sales by Countries
- 6.1.2 North America Human Milk Oligosaccharides (HMO) Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Human Milk Oligosaccharides (HMO) by Product
- 6.3 North America Human Milk Oligosaccharides (HMO) by End User
7 Europe
- 7.1 Europe Human Milk Oligosaccharides (HMO) by Countries
- 7.1.1 Europe Human Milk Oligosaccharides (HMO) Sales by Countries
- 7.1.2 Europe Human Milk Oligosaccharides (HMO) Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Human Milk Oligosaccharides (HMO) by Product
- 7.3 Europe Human Milk Oligosaccharides (HMO) by End User
8 Asia Pacific
- 8.1 Asia Pacific Human Milk Oligosaccharides (HMO) by Countries
- 8.1.1 Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Countries
- 8.1.2 Asia Pacific Human Milk Oligosaccharides (HMO) Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Human Milk Oligosaccharides (HMO) by Product
- 8.3 Asia Pacific Human Milk Oligosaccharides (HMO) by End User
9 Central & South America
- 9.1 Central & South America Human Milk Oligosaccharides (HMO) by Countries
- 9.1.1 Central & South America Human Milk Oligosaccharides (HMO) Sales by Countries
- 9.1.2 Central & South America Human Milk Oligosaccharides (HMO) Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Human Milk Oligosaccharides (HMO) by Product
- 9.3 Central & South America Human Milk Oligosaccharides (HMO) by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Human Milk Oligosaccharides (HMO) by Countries
- 10.1.1 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Countries
- 10.1.2 Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Human Milk Oligosaccharides (HMO) by Product
- 10.3 Middle East and Africa Human Milk Oligosaccharides (HMO) by End User
11 Company Profiles
- 11.1 Abbott
- 11.1.1 Abbott Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Abbott Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Abbott Human Milk Oligosaccharides (HMO) Products Offered
- 11.1.5 Abbott Recent Development
- 11.2 Inbiose
- 11.2.1 Inbiose Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Inbiose Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Inbiose Human Milk Oligosaccharides (HMO) Products Offered
- 11.2.5 Inbiose Recent Development
- 11.3 Company two
- 11.3.1 Company two Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Company two Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Company two Human Milk Oligosaccharides (HMO) Products Offered
- 11.3.5 Company two Recent Development
- 11.4 Jennewein Biotechnologie
- 11.4.1 Jennewein Biotechnologie Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Products Offered
- 11.4.5 Jennewein Biotechnologie Recent Development
- 11.5 Glycom
- 11.5.1 Glycom Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Glycom Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Glycom Human Milk Oligosaccharides (HMO) Products Offered
- 11.5.5 Glycom Recent Development
- 11.6 ZuChem
- 11.6.1 ZuChem Company Details
- 11.6.2 Company Business Overview
- 11.6.3 ZuChem Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 ZuChem Human Milk Oligosaccharides (HMO) Products Offered
- 11.6.5 ZuChem Recent Development
- 11.7 Dextra Laboratories
- 11.7.1 Dextra Laboratories Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Dextra Laboratories Human Milk Oligosaccharides (HMO) Products Offered
- 11.7.5 Dextra Laboratories Recent Development
12 Future Forecast
- 12.1 Human Milk Oligosaccharides (HMO) Market Forecast by Regions
- 12.1.1 Global Human Milk Oligosaccharides (HMO) Sales Forecast by Regions 2019-2025
- 12.1.2 Global Human Milk Oligosaccharides (HMO) Revenue Forecast by Regions 2019-2025
- 12.2 Human Milk Oligosaccharides (HMO) Market Forecast by Product
- 12.2.1 Global Human Milk Oligosaccharides (HMO) Sales Forecast by Product 2019-2025
- 12.2.2 Global Human Milk Oligosaccharides (HMO) Revenue Forecast by Product 2019-2025
- 12.3 Human Milk Oligosaccharides (HMO) Market Forecast by End User
- 12.4 North America Human Milk Oligosaccharides (HMO) Forecast
- 12.5 Europe Human Milk Oligosaccharides (HMO) Forecast
- 12.6 Asia Pacific Human Milk Oligosaccharides (HMO) Forecast
- 12.7 Central & South America Human Milk Oligosaccharides (HMO) Forecast
- 12.8 Middle East and Africa Human Milk Oligosaccharides (HMO) Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Human Milk Oligosaccharides (HMO) Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Human Milk Oligosaccharides (HMO) . Industry analysis & Market Report on Human Milk Oligosaccharides (HMO) is a syndicated market report, published as Global Human Milk Oligosaccharides (HMO) Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Human Milk Oligosaccharides (HMO) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
